The BBC news agency reported that Initial tests indicated that COVID-19 vaccine Developed by Astra Seneca and the University of Oxford Provides limited protection in patients
slotxo infected with COVID-19. A South African strain with mild and moderate symptoms, however, AstraZeneca expressed confidence that the company's vaccine could protect against COVID-19. African species in patients with severe symptoms are possible.
The information was first disclosed by the Financial Times before it was confirmed by AstraZeneca. The information was obtained from a study of 2,000 patients, however, it has not been reviewed by experts at all.
A spokesman for AstraZeneca said: It is not yet possible to confirm whether the vaccine against COVID-19 The company will be able to prevent patients from contracting COVID-19. Can a South African breed with severe symptoms and require hospitalization? Because most of the people involved in the study were healthy adults or young people.
AstraZeneca, however, expressed confidence that the COVID-19 vaccine was Of the company will be able to show efficacy in patients with severe symptoms Because it uses a neutral antibody formation similar to the COVID-19 vaccine. Of other companies
The information was released after new data released Friday (Feb. 5) indicating the COVID-19 vaccine. Developed by Astra Seneca and the University of Oxford Effective in preventing the COVID-19 virus A new strain found in England at the same level as that of the original strain of the novel coronavirus.